T 0904/98 (Dermal Aspirin/GUNDERSON) of 20.07.2000
- European Case Law Identifier
- ECLI:EP:BA:2000:T090498.20000720
- Date of decision
- 20 July 2000
- Case number
- T 0904/98
- Petition for review of
- -
- Application number
- 92912205.9
- IPC class
- A61K 31/60
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Suppression of thromboxane levels by percutaneous administration of aspirin
- Applicant name
- GUNDERSON MEDICAL FOUNDATION, LTD. et al
- Opponent name
- -
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 52(1) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973
- Keywords
- Novelty (yes)
Inventive step (yes); non-obvious solution; finding that dermal aspirin does not affect prostaglandin levels, while effectively suppressing thromboxane levels in a mammalian subject, not a mere bonus effect, but achievement of a desirable therapeutic goal in its own right - Catchword
- -
- Cited cases
- G 0005/83
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision of the Examining Division is set aside.
2. The case is remitted to the department of the first instance with the order that a patent be granted on the basis of claims 1 to 15 of the "Main Request" filed during oral proceedings and a description to be adapted thereto.